Related Experiment Video

Updated: Apr 4, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.6K

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1

Anuja Sathe1, Nicole Koshy1, Sebastian C Schmid1

  • 1Department of Urology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Department of Nuclear Medicine, Rostock University Medical Centre (SMS, BJK), Rostock, Germany.

The Journal of Urology
|August 31, 2015
PubMed
Abstract

Insights

CDK4/6 inhibitors show promise for retinoblastoma-positive bladder cancer. These drugs reduce tumor growth by targeting the retinoblastoma signaling network, offering a potential new therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The retinoblastoma (RB) signaling network is frequently altered in advanced bladder cancer.
  • Identifying therapeutic targets and predictive biomarkers is crucial for effective treatment stratification.

Purpose of the Study:

  • To investigate Cyclin-Dependent Kinase (CDK)4/6 as a potential therapeutic target in bladder cancer.
  • To identify biomarkers for patient stratification based on retinoblastoma (RB) status.

Main Methods:

  • Analysis of genetic alterations in bladder cancer using public databases (TCGA, COSMIC, CCLE).
  • In vitro assessment of CDK4/6 inhibitors (PD-0332991, LY2835219) in bladder cancer cell lines, evaluating cell viability, apoptosis, and cell cycle.
  • In vivo efficacy studies using 3D xenografts on the chicken chorioallantoic membrane.

Main Results:

  • CDK4/6 inhibitor treatment reduced proliferation in RB-positive bladder cancer cell lines.
  • Combination therapy with PD-0332991 and cisplatin showed synergistic effects.
  • Inhibition of CDK4/6 decreased RB phosphorylation and transcript levels, leading to G0/G1 to S-phase cell cycle arrest.

Conclusions:

  • CDK4/6 inhibition represents a potential therapeutic strategy for RB-positive bladder cancer.
  • The mechanism likely involves negative regulation of RB transcription.
  • RB status serves as a potential biomarker for patient selection.
Keywords:
biological markerscyclin-dependent kinase inhibitor proteinspalbociclibretinoblastomaurinary bladder neoplasms

More Related Videos

Inducible and Reversible Dominant-negative DN Protein Inhibition08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K